Development and validation of a novel platform-independent metastasis signature in human breast cancer.
about
Improving the Prognostic Ability through Better Use of Standard Clinical Data - The Nottingham Prognostic Index as an Example.Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer.Live detection and purification of cells based on the expression of a histone chaperone, HIRA, using a binding peptide.Integrative Analysis with Monte Carlo Cross-Validation Reveals miRNAs Regulating Pathways Cross-Talk in Aggressive Breast Cancer.
P2860
Development and validation of a novel platform-independent metastasis signature in human breast cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Development and validation of ...... nature in human breast cancer.
@ast
Development and validation of ...... nature in human breast cancer.
@en
type
label
Development and validation of ...... nature in human breast cancer.
@ast
Development and validation of ...... nature in human breast cancer.
@en
prefLabel
Development and validation of ...... nature in human breast cancer.
@ast
Development and validation of ...... nature in human breast cancer.
@en
P2093
P2860
P1433
P1476
Development and validation of ...... nature in human breast cancer.
@en
P2093
Felix Y Feng
Kari Wilder-Romans
Lori J Pierce
Mark Shilkrut
Meilan Liu
Shuang G Zhao
Theodore S Lawrence
P2860
P304
P356
10.1371/JOURNAL.PONE.0126631
P407
P50
P577
2015-05-14T00:00:00Z